文献速递治疗药物监测与药物基因组学特殊人群用药

Fraser方程估算危重症成人游离丙戊酸浓度的外部验证

External Validation of the Fraser Equation for Estimation of Free Valproate Concentrations in Critically Ill Adults.
PubMed 文献 · Pharmacotherapy · 2025-11-17

本研究在两家学术中心纳入315例成人ICU患者共556对游离与总丙戊酸浓度数据,外部验证Fraser方程估算游离丙戊酸浓度的性能。结果显示Fraser方程估算值与实测值相关系数r=0.728,平均偏差-2.77 mg/L(95% LOA -18.9, 13.4),71%估算治疗一致,高于Doré方程的61.9%(p=0.001),但随实测浓度升高低估加重,准确性不足以替代直接测定。

要点

  • Fraser方程估算游离丙戊酸与实测值中度相关(r=0.728),平均偏差-2.77 mg/L。
  • 71%的Fraser方程估算治疗一致,高于Doré方程的61.9%(p=0.001)。
  • 实测游离丙戊酸浓度越高,Fraser方程低估越明显,不能替代直接测定。

核心结论

  • Fraser方程中度准确,71%的游离丙戊酸浓度估算与实测治疗一致。
  • 随实测游离丙戊酸浓度升高,Fraser方程低估加重,提示应直接测定游离丙戊酸浓度。
  • 在无法直接测定或结果回报慢的中心,Fraser方程可辅助治疗决策,但准确性不足以替代直接测定。

研究设计与样本

  • 外部验证研究,纳入两家学术中心成人ICU患者315例,共556对同时测定的游离与总丙戊酸浓度。
  • 使用Fraser方程估算游离丙戊酸浓度,该方程纳入总丙戊酸、白蛋白、BUN及是否使用丙泊酚或阿司匹林。
  • 主要结局为Fraser方程性能,采用Bland-Altman方法评估,并与Doré方程比较。

主要发现

  • Fraser方程估算值与实测值相关(r=0.728),平均偏差-2.77 mg/L(95% LOA -18.9, 13.4)。
  • 随实测游离丙戊酸浓度升高,Fraser方程低估程度加重。
  • Fraser方程估算治疗一致率为71%,Doré方程为61.9%(p=0.001)。
  • Fraser方程修改后性能略有改善,但未能克服高浓度时的低估加重。

关键数值与推荐

  • 治疗一致的目标游离丙戊酸范围为5-15 mg/L。
  • Fraser方程估算治疗一致率71%,Doré方程61.9%(p=0.001)。
  • Fraser方程平均偏差-2.77 mg/L,95% LOA -18.9至13.4 mg/L。

临床怎么用

  • 在无法直接测定游离丙戊酸或结果回报慢的中心,Fraser方程可辅助治疗决策。
  • Fraser方程准确性不足以替代直接测定游离丙戊酸浓度。
  • 高游离丙戊酸浓度时方程低估明显,应优先直接测定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Critically ill patients may be overexposed to valproate because altered protein binding leads to a disproportionate free valproate fraction. The Fraser equation was derived and internally validated to estimate critically ill patients' free valproate concentrations, but it requires external validation. METHODS: Adult intensive care unit (ICU) patients at two academic centers with concurrently measured free and total valproate concentrations were included. Free valproate concentrations were estimated using the Fraser equation which includes total valproate, albumin and BUN concentration, and whether the patient received propofol or aspirin. The primary outcome was Fraser equation performance, assessed using Bland-Altman methods. Comparative performance against estimates from the Doré equation (an alternative predictive equation), therapeutic concordance using a target free valproate range of 5-15 mg/L, and equation improvements were explored. RESULTS: Overall, 315 patients and 556 free-total valproate concentration pairs were included. The mean (±SD) age was 58 (±17) years and 90 (29%) patients were on valproate prior to hospital admission. The Fraser equation estimated free valproate concentrations were correlated with measured concentrations (r = 0.728) with a negative bias (mean bias -2.77 mg/L, 95% LOA -18.9, 13.4). The Fraser equation increasingly underestimated measured concentrations as measured concentrations increased. 71% of Fraser equation estimates were therapeutically concordant (e.g., estimate and measured both within reference range) compared to 61.9% of Doré estimates (p = 0.001). Fraser equation modifications led to minor performance improvements but did not overcome worsening underestimation with higher measured free valproate concentrations. CONCLUSION: The Fraser equation was moderately accurate and corresponded with an appropriate interpretation for 71% of free valproate concentrations. Worse underestimation with higher measured free valproate concentrations suggests direct measurement of free valproate concentrations is warranted. While the Fraser equation could complement therapeutic decision making at centers where direct free valproate measurements are unavailable or slow to return, its accuracy is currently insufficient to replace direct measurement.

来源:Pharmacotherapy,查看原文。版权归原作者所有。

引用

  1. Webb AJ, Brown CS, Liu J, et al. External Validation of the Fraser Equation for Estimation of Free Valproate Concentrations in Critically Ill Adults. Pharmacotherapy. 2025. PMID: 41246825. doi:10.1002/phar.70079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。